🇺🇸 Diphenhydramine HCL in United States

FDA authorised Diphenhydramine HCL on 13 February 1978

Marketing authorisations

FDA — authorised 13 February 1978

  • Application: NDA018066
  • Marketing authorisation holder: CHATTEM
  • Local brand name: UNISOM
  • Indication: TABLET — ORAL
  • Status: approved

Read official source →

FDA

  • Application: NDA019440
  • Marketing authorisation holder: PFIZER
  • Local brand name: UNISOM
  • Indication: CAPSULE — ORAL
  • Status: approved

Read official source →

Other Allergy/Immunology approved in United States

Frequently asked questions

Is Diphenhydramine HCL approved in United States?

Yes. FDA authorised it on 13 February 1978; FDA has authorised it.

Who is the marketing authorisation holder for Diphenhydramine HCL in United States?

CHATTEM holds the US marketing authorisation.